Cancer hepatic treatment, Hepatocellular Carcinoma: Treating Liver Cancer oncocytic papilloma nasal

Language of Keywords: English; Romanian Abstract: The prevalence of hepatocellular carcinoma, the most common type of cancer with hepatic origin, has increased and it has a low survival rate. This epidemic is caused by ciuperci sotate viral infections and by the cancer hepatic treatment incidence of non-alcoholic liver cirrhosis. Because the curative options are limited, disease progression creates, both in patients and their families, uncertainty about disease prognosis and treatment options.

Most cases are diagnosed at an end stage of the disease, when the tumor cancer hepatic treatment unresectable, patients experiencing severe recurrent symptoms, such as pain, asthenia and anorexia that affect both their quality of life and functional status.

Această epidemie este cauzată de infecţiile virale cronice şi de incidenţa crescută a cirozelor hepatice non-alcoolice. Deoarece opţiunile curative sunt limitate, evoluţia bolii creează atât în rândul pacienţilor cât şi în cadrul familiilor acestora, incertitudine cu privire la prognosticul bolii şi la opţiunile de tratament.

Majoritatea cazurilor sunt diagnosticate într-un stadiu final al bolii, când tumora nu este rezecabilă, pacienţii prezentându-se cu simptome recurente severe precum durerea, astenia şi anorexia ce le afectează atât calitatea vieţii cât şi statusul funcţional.

However, users may print, download, or email articles for individual use.

This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.

Copyright applies to all Abstracts.